X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.120
-0.090 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
4.210
+0.090 (2.18%)
Pre-market: Apr 29, 2026, 7:47 AM EDT
X4 Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -79.2 | -37.45 | -101.17 | -93.87 | -88.7 | |
| Depreciation & Amortization | 1.28 | 0.8 | 0.42 | 0.51 | 0.5 | |
| Other Amortization | 0.87 | 0.86 | 0.93 | 0.92 | 0.76 | |
| Loss (Gain) From Sale of Assets | - | -105 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 9.76 | |
| Stock-Based Compensation | 4.3 | 8.2 | 8.69 | 5.2 | 6.18 | |
| Other Operating Activities | -10.28 | -0.98 | -5.72 | 4.4 | 2.1 | |
| Change in Accounts Receivable | 0.5 | -1.07 | - | - | - | |
| Change in Inventory | -1.66 | -2.82 | - | - | - | |
| Change in Accounts Payable | -2.98 | -0.29 | 1.23 | 3.43 | 1.17 | |
| Change in Unearned Revenue | 1.09 | - | - | - | - | |
| Change in Other Net Operating Assets | 0.48 | 6.85 | -0.89 | 2.31 | -2.66 | |
| Operating Cash Flow | -85.62 | -130.9 | -96.51 | -77.1 | -70.91 | |
| Capital Expenditures | - | -0.33 | -0.06 | -0.1 | -0.62 | |
| Sale of Property, Plant & Equipment | - | 105 | - | - | - | |
| Sale (Purchase) of Intangibles | -3 | -7 | - | - | - | |
| Investment in Securities | 11.15 | -30.68 | -14.82 | - | - | |
| Investing Cash Flow | 8.15 | 66.99 | -14.88 | -0.1 | -0.62 | |
| Long-Term Debt Issued | - | 20 | 22.5 | - | - | |
| Long-Term Debt Repaid | - | - | -2.06 | -0.8 | - | |
| Net Debt Issued (Repaid) | - | 20 | 20.44 | -0.8 | - | |
| Issuance of Common Stock | 238.63 | 0.29 | 68.71 | 122.84 | 76.25 | |
| Repurchase of Common Stock | - | - | - | -0.01 | -2 | |
| Other Financing Activities | - | - | -0.63 | -4.8 | - | |
| Financing Cash Flow | 238.63 | 20.29 | 88.52 | 117.23 | 74.25 | |
| Foreign Exchange Rate Adjustments | 0.21 | -0.16 | 0.1 | -0.11 | -0.32 | |
| Net Cash Flow | 161.38 | -43.77 | -22.78 | 39.92 | 2.41 | |
| Free Cash Flow | -85.62 | -131.23 | -96.57 | -77.21 | -71.52 | |
| Free Cash Flow Margin | -243.84% | -5132.07% | - | - | - | |
| Free Cash Flow Per Share | -2.02 | -19.58 | -16.29 | -36.46 | -83.33 | |
| Cash Interest Paid | 8.05 | 7.77 | 4.6 | 3.01 | 2.91 | |
| Cash Income Tax Paid | 0.34 | - | - | - | - | |
| Levered Free Cash Flow | -57.36 | -83.72 | -59.79 | -44.23 | -43.05 | |
| Unlevered Free Cash Flow | -52.68 | -79.09 | -57.1 | -42.65 | -41.53 | |
| Change in Working Capital | -2.58 | 2.68 | 0.34 | 5.74 | -1.5 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.